Korro Bio, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 19.56 million compared to USD 19.61 million a year ago. Basic loss per share from continuing operations was USD 2.44 compared to USD 72.2 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
49.15 USD | +7.20% |
|
+34.55% | +2.55% |
Jul. 01 | Korro Bio Joins Russell 2000, 3000, Microcap Indexes | MT |
Jul. 01 | Korro Bio, Inc.(NasdaqCM:KRRO) added to Russell Small Cap Comp Value Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.55% | 456M | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- KRRO Stock
- News Korro Bio, Inc.
- Korro Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024